Skip to main content
Premium Trial:

Request an Annual Quote

UPMC to Build $300M Center for 'Innovative' Biomedical Science

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Pittsburgh Medical Center said today that it plans to invest $294 million in building a research center in Pittsburgh that will focus on personalized medicine and the biology of cancer and aging.

The 350,000-square-foot Center for Innovative Science will be located at the site of the former Ford Motor Co. Building on Centre Ave., which UPMC bought in 2007, and will support 375 new scientific and administrative jobs.

UPMC said it has started a national recruitment campaign with the University of Pittsburgh to find a leader in genetics and genomics to focus on research into the biological underpinnings of cancer, the role of viruses, and the cellular changes that are part of the aging process.

“This major investment in good science will help us to develop the personalized treatments necessary to improve the effectiveness of health care. For diseases like cancer, we will identify the genetic and environmental factors that determine the susceptibility of each individual and the best course and type of treatment," UPMC Chief Medical and Scientific Officer Steven Shapiro said in a statement.

“With recent advances that have been made in such fields as genetics, genomics and computational biology, the time is right to challenge the conventional paradigms that have guided most medical research to this point,” Shapiro continued.

He said the medical center's large population of patients and its investments in gathering and analyzing large volumes of data make it "uniquely positioned" to pursue this type of science.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.